KLK3 and metastatic neoplasm: By contrast, PSA concentration at diagnosis and Gleason Grade Group were poorly or not correlated with baseline mCRPC ctDNA% (Fig. 2A, B) regardless of diagnosis of de novo or metachronous metastatic disease (p = 0.71; two-way ANOVA test for interaction).